About
Meiogenix is a pioneering agriculture biotechnology company headquartered in Durham, North Carolina, with offices in Paris, France. The company has developed a proprietary recombination platform based on Chromosome Editing that fundamentally transforms how plant breeders access and utilize genetic diversity. Traditional breeding methods are constrained by suppressed recombination in cold genomic regions such as pericentromeres, leaving roughly one-quarter of beneficial genes inaccessible. Meiogenix's technology overcomes this barrier, having demonstrated a 10x increase in targeted recombination in corn. The platform supports a broad range of breeding applications including trait introgression to accelerate transfer of desirable traits into commercial germplasms, linkage drag separation to isolate valuable traits from negative ones, complex trait stacking, and cold zone recombination to access previously locked genetics. Meiogenix partners with breeders across both specialty crops (tomato, fruits, vegetables) and major field crops (corn, rice, wheat, soybean). The company operates through large-scale technology licensing partnerships — generating value via license fees, milestones, and royalties — and co-development agreements with leading agricultural organizations. Meiogenix is positioned at the frontier of sustainable agriculture, enabling faster genetic gain and variety development to address global food security challenges driven by climate change and narrowing genetic diversity.
Key Features
- Targeted Recombination Platform: Proprietary technology enabling up to 10x increase in targeted recombination, unlocking previously inaccessible genetic regions in crops like corn, wheat, and rice.
- Trait Introgression & Linkage Drag Reduction: Accelerates the transfer of valuable traits into commercial germplasms while cleanly separating them from linked negative traits.
- Cold Zone Recombination: Accesses deleterious alleles and hard-to-reach genetic regions in pericentromeric zones that conventional breeding cannot reach.
- Technology Licensing Partnerships: Offers large-scale licensing deals to seed companies and breeders worldwide, structured around license fees, milestones, and royalties.
- Broad Crop Coverage: Supports both specialty crops (tomato, fruits, vegetables) and major field crops (corn, rice, wheat, soybean) through tailored breeding programs.
Use Cases
- Seed companies seeking to accelerate the development of climate-resilient crop varieties by accessing previously locked genetic diversity.
- Agricultural breeders working to introgress disease-resistance or yield-boosting traits into commercial germplasms more rapidly.
- Research institutions partnering with Meiogenix to study and apply targeted recombination in genomic research programs.
- Agribusinesses aiming to separate valuable traits from linked negative traits (linkage drag) in major field crops like corn and wheat.
- Specialty crop developers looking to stack complex traits in tomato, fruits, and vegetables to meet market and sustainability demands.
Pros
- Proven Technology Breakthrough: Demonstrated 10x increase in targeted recombination in corn, with measurable scientific validation of its platform.
- Addresses a Critical Industry Gap: Solves a longstanding limitation in conventional breeding by unlocking ~25% of beneficial genes previously inaccessible due to suppressed recombination.
- Flexible Partnership Models: Offers licensing, milestone-based, and royalty structures that suit a wide range of agricultural company sizes and needs.
Cons
- Not a Self-Serve Software Tool: Meiogenix is a B2B biotech company requiring formal partnership agreements — not a plug-and-play digital platform accessible to individuals.
- Limited Public Pricing Transparency: Licensing and partnership costs are not publicly disclosed and require direct engagement with the Meiogenix team.
Frequently Asked Questions
What is Chromosome Editing as used by Meiogenix?
Chromosome Editing refers to Meiogenix's proprietary method of controlling and targeting the recombination process during meiosis (cell division) in plants, allowing breeders to access genetic diversity that is normally locked in cold genomic regions.
Which crops does Meiogenix's technology support?
The technology supports a wide range of crops including major field crops such as corn, rice, wheat, and soybean, as well as specialty crops like tomato, fruits, and vegetables.
How does Meiogenix partner with agricultural companies?
Meiogenix offers technology licensing partnerships structured around license fees, development milestones, and royalties, enabling breeders to integrate the recombination platform into their existing programs.
What problem does Meiogenix solve in plant breeding?
Conventional breeding cannot access roughly one-quarter of beneficial genes due to suppressed recombination in pericentromeric (cold zone) regions of the genome. Meiogenix's platform unlocks these regions, dramatically expanding the genetic toolkit available to breeders.
Where is Meiogenix located?
Meiogenix operates from two locations: its U.S. headquarters at 9 Laboratory Drive, Suite 267, Durham, North Carolina, and its European office at 6 Avenue Franklin Roosevelt, Paris, France.
